Lupus Clinical Trials

A listing of Lupus medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 119 clinical trials
Anifrolumab Asian PhIII Efficacy Study for Systemic Lupus Erythematosus (SLE)

The purpose of this study is to evaluate the efficacy and safety of an intravenous treatment regimen of anifrolumab versus placebo in Asian participants with active systemic lupus erythematosus

  • 0 views
  • 29 Jul, 2022
  • 39 locations
Efficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus Erythematosus

The primary objective is to evaluate the efficacy and safety of efavaleukin alfa in subjects with active systemic lupus erythematosus.

  • 60 views
  • 11 Aug, 2022
  • 135 locations
A Study to Evaluate the Efficacy and Safety of BIIB059 in Adult Participants With Active Systemic Lupus Erythematosus Receiving Background Nonbiologic Lupus Standard of Care (TOPAZ-1)

The primary objective of this study is to demonstrate efficacy of BIIB059 compared with placebo in participants with active systemic lupus erythematosus (SLE), who are receiving background lupus

rheumatism
antimalarials
  • 0 views
  • 13 May, 2022
  • 35 locations
A Study to Evaluate the Efficacy and Safety of BIIB059 in Adult Participants With Active Systemic Lupus Erythematosus Receiving Background Nonbiologic Lupus Standard of Care (TOPAZ-2)

The primary objective of this study is to demonstrate efficacy of BIIB059 compared with placebo in participants with active systemic lupus erythematosus (SLE), who are receiving background lupus

rheumatism
antimalarials
  • 0 views
  • 14 May, 2022
  • 33 locations
Study of VIB7734 for the Treatment of Moderate to Severely Active SLE (RECAST SLE)

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of VIB7734 for the Treatment of Moderate to Severely Active Systemic Lupus Erythematosus in approximately 195

  • 0 views
  • 18 Apr, 2022
  • 70 locations
Multiple Ascending Dose Study of MHS552 in Adults Participants With Systemic Lupus Erythematosus (SLE)

The purpose of this two-part multiple ascending dose study is to evaluate the safety and tolerability of multiple doses of MHS552 in adults with mild to moderately active Systemic Lupus

cutaneous lupus
prednisone
quinacrine
methotrexate
azathioprine
  • 0 views
  • 20 Jun, 2022
  • 1 location
Memantine for the Treatment of Cognitive Impairment in Systemic Lupus Erythematosus (ClearMEMory)

Lupus Erythematosus (SLE). A single nucleotide polymorphism (SNP) in this gene encodes for increased NMDA receptor activity. Based on the potential function of the associated SNP and published

  • 21 views
  • 26 May, 2022
  • 1 location
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of E6742 in Systemic Lupus Erythematosus Participants

The primary purpose of the study is to evaluate the safety and tolerability of multiple oral doses of E6742 in participants with systemic lupus erythematosus (SLE).

antinuclear antibody
body mass index
  • 0 views
  • 23 Jul, 2022
  • 11 locations
Efficacy and Safety of SAR441344 in the Treatment of Systemic Lupus Erythematosus (APATURA)

the treatment of participants aged 18 to 70 years with active Systemic Lupus Erythematosus (SLE). Study details include: Study duration: 36 weeks Treatment duration: 24 weeks

lupus
antinuclear antibody
arthritis
rash
  • 3 views
  • 10 Aug, 2022
  • 5 locations
BCMA-CD19 cCAR T Cell Treatment of Relapsed/Refractory Systemic Lupus Erythematosus (SLE)

This is a phase I, interventional, single arm, open label, treatment study to evaluate the safety and tolerability of BCMA-CD19 cCAR T cells in patients with relapsed and/or refractory SLE.

  • 0 views
  • 09 Aug, 2022
  • 1 location